化工儀器網(wǎng)
詳細(xì)介紹
IN VIVO TRANSFECTION KITS: PEG-Liposome, Nanoparticle, Polymer, Lipid, Tissue-targeted
貨號(hào)：5011， LIPID In Vivo Transfection Kit, 1.5 mL （30 injections）￥12530元
貨號(hào)：5021， POLYMER In Vivo Transfection Kit, 1.5 mL （30 injections） ￥13090元
貨號(hào)：5031 ，NANOPARTICLE In Vivo Transfection Kit, 1.5 mL （30 injections） ￥13370元
貨號(hào)：5041， PEG-Liposome In Vivo Transfection Kit, 1.5 mL （30 injections） ￥13650元
貨號(hào)：5051,PANCREAS-targeted In Vivo Transfection Reagent - 1.5 mL （30 injections）￥13930元
貨號(hào)：5061 LIVER-targeted In Vivo Transfection Reagent - 1.5 mL （30 injections） ￥13930元
貨號(hào)：5071 KIDNEY-targeted In Vivo Transfection Reagent - 1.5 mL （30 injections） ￥13930元
LIPID-based In Vivo Transfection Kit for Rodents （Mouse, Rat）
- Cationic lipid liposome-based siRNA and plasmid DNA in vivo delivery reagent
- Efficient delivery to the liver, pancreas, kidney, and certain tumor types via systemic administration
- Complete product support information is available at: LIPID In Vivo Transfection Kit
Figure 1. Systemic administration （i.v.） of Lipid-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
Figure 2. Intratumoral administration （i.t.） of Lipid-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
POLYMER-based In Vivo Transfection Kit for Rodents （Mouse, Rat）
- Biodegradable polymer-based in vivo reagent
- Efficient delivery to the lung, liver, kidney, and spleen via systemic administration
- Complete product support information is available at: POLYMER In Vivo Transfection Kit
Figure 3. Systemic administration （i.v.） of Polymer-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
Figure 4. Intratumoral administration （i.t.） of Polymer-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
NANOPARTICLE-based In Vivo Transfection Kit for Rodents （Mouse, Rat）
- Nanoparticle-based reagent
- Efficient delivery to the heart, lung, liver, pancreas, kidney, and multiple tumor types via systemic administration
- Complete product support information is available at: NANOPARTICLE In Vivo Transfection Kit
Figure 5. Systemic administration （i.v.） of Nanoparticle-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
Figure 6. Intratumoral administration （i.t.） of Nanoparticle-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
PEG-Liposome In Vivo Transfection Kit for Rodents （Mouse, Rat）
- PEGylated liposome based reagent
- Efficient delivery to the spleen, kidney, pancreas, liver, and multiple tumor types via systemic administration
- Complete product support information is available at: PEG-Liposome In Vivo Transfection Kit
Figure 7. Systemic administration （i.v.） of Liposome-PEG based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
Figure 8. Intratumoral administration （i.t.） of Liposome-PEG based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD （n=6）.
Tissue-targeted In Vivo Transfection Reagents for Rodents （Mouse, Rat）:
- LIVER-targeted in vivo reagent
- KIDNEY-targeted in vivo reagent
- PANCREAS-targeted in vivo reagent